SEC 13F Intelligence

Boxer Capital, LLC / SPRY

Boxer Capital, LLC’s Ars Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Ars Pharmaceuticals Inc (SPRY)? Not currently — the last reported position was 1.68M shares worth $17M in Q3 2021; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$17M
Q3 2021
Shares
1.68M
% of Portfolio
+0.58%
Quarters Held
4
position exited

Position History SPRY

Reported value by quarter
Q4 ’20: $78MQ4 ’20Q1 ’21: $73MQ1 ’21Q2 ’21: $52MQ2 ’21Q3 ’21: $17MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20211.68M$17M+0.58%
Q2 20211.68M$52M+1.83%
Q1 20211.68M$73M+2.48%
Q4 20201.68M$78M+2.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of SPRY.